Activities of Renate SOMMER related to 2017/2254(INI)
Plenary speeches (1)
A European One Health Action Plan against Antimicrobial Resistance (debate) DE
Shadow reports (1)
REPORT on a European One Health Action Plan against Antimicrobial Resistance (AMR) PDF (545 KB) DOC (117 KB)
Amendments (24)
Amendment 20 #
Motion for a resolution
Recital A
Recital A
A. whereas the excessive and inappropriate use of antibiotics and poor infection control practices have progressively rendered antimicrobial resistance (AMR) a massive threat to humankind;
Amendment 31 #
Motion for a resolution
Recital A b (new)
Recital A b (new)
Ab. whereas prudent antibiotic use and infection prevention and control in all healthcare sectors are cornerstones for effectively preventing the development and transmission of antibiotic-resistant bacteria;
Amendment 37 #
Motion for a resolution
Recital B
Recital B
B. whereas the misuse of antibiotics is eroding their efficacy and leading to the spread of highly resistant bacteria that are especially resistant to last-line antibiotics; whereas according to data provided by the OECD, an estimated 700 000 deaths worldwide may be caused by AMR every year;
Amendment 39 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas vaccinations and rapid diagnostic tools (RDT) have the potential to limit antibiotic abuse; whereas RDT allow healthcare professionals to quickly diagnose a patient with a bacterial or viral infection and, consequently, to reduce the misuse of antibiotics and the risk of resistance developing1a; _________________ 1aWHO Global guidelines on the prevention of surgical site infection (2016), available at: http://www.who.int/gpsc/ssi-guidelines/en/
Amendment 49 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas active screening programs with RDT have been proven to significantly contribute to the control of HAI and the reduction of the spread within hospitals and between patients1a _________________ 1aCelsus Academie voor Betaalbare zorg. Cost-effectiveness of policies to limit antimicrobial resistance in dutch healthcare organisations. Research report. January 2016. Available at: https://goo.gl/wAeN3L
Amendment 51 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas good hand hygiene, in the form of effective hand washing and hand drying, can contribute to preventing the transmission of infectious diseases and AMR;
Amendment 52 #
Motion for a resolution
Recital C b (new)
Recital C b (new)
Cb. whereas the use of medical devices can prevent Surgical Site Infections and therefore prevent and control the development of AMR1a; _________________ 1aWHO Global guidelines on the prevention of surgical site infection (2016), available at: http://www.who.int/gpsc/ssi-guidelines/en/
Amendment 53 #
Motion for a resolution
Recital D
Recital D
Amendment 80 #
Motion for a resolution
Subheading 1
Subheading 1
Amendment 90 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Stresses that pollution of water and soil by human and veterinary antibiotic residues is a growing problem and that the environment itself is a potential source of new resistant micro- organisms; calls therefore on the Commission to pay significantly more attention to the environment as part of the concept of 'One Health';
Amendment 100 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that the appropriat, in principle, the emergence and sprudent use of antimicrobials is essential to limiting the emergence of AMR in human healthcare, animal husbandry and aquaculture; stresses that there are considerable differences in the way Member Stateead of antibiotic- resistant bacteria can be fought most effectively at source, in particular through the proper therapeutic use of antibiotics in humans and animals, so as to reduce the entry of antibiotics handle and address AMR; calls on the Commission to consider mandatory routine collection and submission of monitoring data at EU level and to establish indictors to measure progress in the fight against AMRtibiotic- resistant bacteria into the environment; underlines, in this connection, the need for a cross-sectoral and cross-media implementation of the concept of 'One Health', which is not yet sufficiently achieved in the Commission's action plan;
Amendment 118 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Regrets that the Commission's strategic approach, which is basically right, is all too often limited to declarations of intent and calls on the Commission to spell out its approach;
Amendment 122 #
Motion for a resolution
Paragraph 2 b (new)
Paragraph 2 b (new)
2b. Stresses that there are considerable differences in the ways in which Member States handle and try to fight AMR; stresses that joint EU action against the increasing threat to human and animal health and the environment posed by antibiotic-resistant bacteria can only succeed if it is based on standardised data and calls on the Commission to develop and propose appropriate procedures and indicators to this end;
Amendment 169 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Emphasises that infection prevention, biosecurity measures, active screening programs, and control practices are critical in the control of all infectious microorganisms as they reduce the need for antimicrobials and consequently opportunities for microorganisms to develop and spread resistance;
Amendment 173 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Calls on the Commission, ECDC, and Member States to encourage the use of single-use handtowels in hygiene- sensitive locations, such as healthcare institutions, food processing facilities, and nurseries.
Amendment 176 #
Motion for a resolution
Paragraph 6 b (new)
Paragraph 6 b (new)
6b. Encourages Member States to prevent the spread of infection by resistant bacteria by implementing active screening programs with rapid diagnostic technologies in order to quickly identify patients infected with multi-drug resistant bacteria and to put in place appropriate infection control measures (e.g. patient isolation, cohorting and reinforced hygiene measures);
Amendment 192 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Urges the Commission and Member States to create harmonised quality standards in EU-wide curricula and proper stewardship forfor their national curricula and to ensure the proper conduct of health professionals in relation to prescribing, dosage, use and disposal of antimicrobials;
Amendment 213 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Is aware that the cost of rapid diagnostic tools (RDT) may exceed the price of antibiotics; calls on the Commission to propose incentives for the industry to develop effective and efficientinexpensive testing methods and calls on health insurance carriers to cover the extra cost arising from the use of RDT, given the long-term benefits of preventing the unnecessary use of antimicrobials;
Amendment 220 #
Motion for a resolution
Paragraph 11
Paragraph 11
Amendment 320 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15 a. Urges the European Commission to consider a new legislative framework to stimulate the development of new antimicrobials for humans, as already requested by the European Parliament on 10 March 2016 on the proposal for a regulation of the European Parliament and of the Council on veterinary medicinal products and in the parliamentary resolution (2015) 0197 of19 May 2015; notes that the Commission “One Health” Action Plan against AMR also commits itself to “analyse EU regulatory tools and incentives - in particular orphan and paediatric legislation – to use them for novel antimicrobials".
Amendment 333 #
Motion for a resolution
Paragraph 17
Paragraph 17
Amendment 348 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18 a. Calls on the Commission to support research on hand hygiene and on the impact of different hand washing and hand drying methods on the transmission of potential pathogens.
Amendment 355 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19 a. Believes that research into fighting antimicrobial resistance is already taking place in many different places in the European Union without there being any adequate overview of the state of research in the EU; suggests, therefore, setting up a dedicated platform at EU level to enable research resources to be used more efficiently in the future;
Amendment 443 #
Motion for a resolution
Paragraph 28 b (new)
Paragraph 28 b (new)
28 b. Calls on the Commission to take the global lead in advocating for evidence-based best practice models for early diagnosis to tackle AMR;